Two generic drug makers are fighting for access to confidential documents related to amendments by Neurim Pharmaceutical of patents covering its sleep drug Circadin, telling the Federal Court on Thursday privilege had been waived after a phone conversation between the company’s founder and her lawyers from DLA Piper.
The ACCC won its case against Sydney-based Unique International College on a “paucity of material”, the Full Federal Court has heard in an appeal of a ruling that found the vocational trainer exploited disadvantaged people and violated the Australian Consumer Law.
Optus was ordered Wednesday to temporarily pull an ad that Telstra alleges makes a false and damaging claim about the superiority of Optus’ mobile network.
The Federal Court has ordered appliance and furniture leasing company Radio Rentals to pay a $2 million penalty for failing to verify consumers’ financial situations before signing them up for leases.
The Full Federal Court on Tuesday dismissed an appeal by aviation services company Aerocare of a ruling rejecting an enterprise agreement the Transport Workers Union called “substandard”.
The financing arrangement underwriting Quinn Emanuel’s shareholder class action against AMP, which will earn its partner Burford Capital a record low 10 percent of any recovery, sets a new standard in class action litigation funding, and is expected to spark greater price competition in the industry.
Drug giant F. Hoffman-La Roche asked the Federal Court Tuesday for an order barring the release of a generic version of its blockbuster cancer drug MabThera by a unit of Swiss rival Novartis, which it claims could lead to “tens of millions of dollars” in losses.
A bidding war erupted Tuesday among law firms angling to lead a $2 billion shareholder class action against AMP, with Maurice Blackburn announcing a “super deal” and Quinn Emanuel besting that with a funding arrangement to “shake up” the market.
The judge overseeing a Maurice Blackburn-led shareholder class action against Commonwealth Bank of Australia over allegedly lax anti-money laundering and anti-terrorism financing controls has struck out a portion of the statement of claim for “pleading deficiencies”.
A judge overseeing a defamation case brought by billionaire Meriton founder Harry Triguboff against Fairfax Media must decide whether an article about the property company that appeared in the Australian Financial Review can be reasonably said to be about Triguboff.